14465 results in Neurology and Clinical Neuroscience
Contents
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp vii-x
-
- Chapter
- Export citation
2 - Drug Development for Alzheimer’s Disease: An Historical Perspective
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 25-33
-
- Chapter
- Export citation
30 - From Trials to Practice: Are We Ready for a Disease-Modifying Treatment?
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 343-353
-
- Chapter
- Export citation
Acknowledgments
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp xx-xx
-
- Chapter
- Export citation
43 - Alzheimer’s Association Funding and Policy for Alzheimer’s Disease Drug Development
- from Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 486-495
-
- Chapter
- Export citation
Contributors
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp xi-xviii
-
- Chapter
- Export citation
Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 465-543
-
- Chapter
- Export citation
36 - The Role of Electroencephalography in Alzheimer’s Disease Drug Development
- from Section 4 - Imaging and Biomarker Development in Alzheimer’s Disease Drug Discovery
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 418-428
-
- Chapter
- Export citation
14 - Trial Site Infrastructure and Management: Importance to Alzheimer’s Disease Drug Development
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 170-176
-
- Chapter
- Export citation
Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 1-72
-
- Chapter
- Export citation
40 - Alzheimer’s Disease Neuroimaging Initiative
- from Section 6 - Public–Private Partnerships in Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 455-464
-
- Chapter
- Export citation
8 - Use of Induced Pluripotent Stem Cell-Derived Neuronal Disease Models from Patients with Familial Early-Onset Alzheimer’s Disease in Drug Discovery
- from Section 2 - Non-clinical Assessment of Alzheimer’s Disease Candidate Drugs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 95-105
-
- Chapter
- Export citation
33 - Brain Imaging for Alzheimer’s Disease Clinical Trials
- from Section 4 - Imaging and Biomarker Development in Alzheimer’s Disease Drug Discovery
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 375-394
-
- Chapter
- Export citation
9 - Preclinical Longitudinal In Vivo Biomarker Platform for Alzheimer’s Disease Drug Discovery
- from Section 2 - Non-clinical Assessment of Alzheimer’s Disease Candidate Drugs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 106-122
-
- Chapter
- Export citation
Section 4 - Imaging and Biomarker Development in Alzheimer’s Disease Drug Discovery
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 361-428
-
- Chapter
- Export citation
Copyright page
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp iv-iv
-
- Chapter
- Export citation
5 - Repurposed Agents in Alzheimer’s Disease Drug Development
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 54-61
-
- Chapter
- Export citation
41 - Financing Alzheimer’s Disease Drug Development
- from Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 465-479
-
- Chapter
- Export citation
34 - Sharing of Alzheimer’s Disease Research Data in the Global Alzheimer’s Association Interactive Network
- from Section 4 - Imaging and Biomarker Development in Alzheimer’s Disease Drug Discovery
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 395-403
-
- Chapter
- Export citation
18 - Clinical Trial Development in Frontotemporal Lobar Degeneration
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 216-231
-
- Chapter
- Export citation